GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ThermoGenesis Holdings Inc (STU:THR) » Definitions » 3-Year EPS without NRI Growth Rate

ThermoGenesis Holdings (STU:THR) 3-Year EPS without NRI Growth Rate : 61.70% (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is ThermoGenesis Holdings 3-Year EPS without NRI Growth Rate?

ThermoGenesis Holdings's EPS without NRI for the three months ended in Mar. 2024 was €-0.42.

During the past 3 years, the average EPS without NRI Growth Rate was 61.70% per year. During the past 5 years, the average EPS without NRI Growth Rate was 51.10% per year. During the past 10 years, the average EPS without NRI Growth Rate was 48.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of ThermoGenesis Holdings was 79.20% per year. The lowest was -278.00% per year. And the median was 13.45% per year.


Competitive Comparison of ThermoGenesis Holdings's 3-Year EPS without NRI Growth Rate

For the Medical Devices subindustry, ThermoGenesis Holdings's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ThermoGenesis Holdings's 3-Year EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ThermoGenesis Holdings's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where ThermoGenesis Holdings's 3-Year EPS without NRI Growth Rate falls into.



ThermoGenesis Holdings 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


ThermoGenesis Holdings  (STU:THR) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


ThermoGenesis Holdings 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of ThermoGenesis Holdings's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


ThermoGenesis Holdings (STU:THR) Business Description

Traded in Other Exchanges
Address
2711 Citrus Road, Rancho Cordova, CA, USA, 95742
ThermoGenesis Holdings Inc develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. It offers the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for bio-manufacturing for immuno-oncology applications.